ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

REGN34 Regeneron Pharmaceuticals Inc

64.06
-1.89 (-2.87%)
14 Mar 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 30.06B30.66B32.16B33.08B34.37B36.09B37.44B37.76B
Total Current Assets 16.91B16.92B18.63B19.48B18.87B19.08B19.33B18.66B
Cash and Equivalents 3.92B1.94B2.15B2.73B2.6B1.92B2.01B2.49B
Total Non-Current Assets 13.15B13.73B13.53B17.75B15.5B17.01B18.11B23.7B
Total Liabilities 6.56B6.64B7.26B7.11B7.38B7.88B8.12B8.41B
Total Current Liabilities 3.1B3.1B3.6B3.42B3.58B3.51B3.66B3.94B
Total Non-Current Liabilities 6.17B6.24B6.36B6.39B6.5B7.08B7.16B7.17B
Common Equity 100k100k100k100k100k100k100k100k
Retained Earnings 24.12B25.09B26.1B27.26B27.98B29.41B30.76B31.67B
Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 8.76B11.73B14.81B17.16B25.43B29.21B33.08B37.76B
Total Current Assets 4.34B6.45B7.69B9.78B14.01B15.88B19.48B18.66B
Cash and Equivalents 812.73M1.47B1.62B2.19B2.89B3.11B2.73B2.49B
Total Non-Current Assets 6.14B8.76B11.09B11.03B18.77B22.66B25.97B29.35B
Total Liabilities 2.62B2.98B3.72B6.14B6.67B6.55B7.11B8.41B
Total Current Liabilities 1.14B1.44B2.1B2.7B3.93B3.14B3.42B3.94B
Total Non-Current Liabilities 2.19B2.24B2.33B6.14B4.71B6.11B6.39B7.17B
Total Equity 6.14B8.76B11.09B11.03B18.77B22.66B25.97B29.35B
Common Equity 112k100k100k100k100k100k100k100k
Retained Earnings 2.95B5.25B7.38B10.89B18.97B23.31B27.26B31.67B